PlainRecalls
FDA Devices Moderate Class II Terminated

Nucleic Acid test intended for screening for MRSA/SA. Each kit has 20 tubes. in vitro diagnostic.

Reported: April 4, 2018 Initiated: October 27, 2017 #Z-1195-2018

Product Description

Nucleic Acid test intended for screening for MRSA/SA. Each kit has 20 tubes. in vitro diagnostic.

Reason for Recall

The cobas MRSA/SA tests may have decreased performance compared to the analytical sensitivity for MSRA detection. A screening failure can lead to potential infection in the colonized patient being tested as well as the spread of MSRA to others. The United States is not impacted, as the cobas MRSA/SA nucleic acid test for use on the cobas liat system is not available in the US.

Details

Units Affected
136 kits
Distribution
Worldwide distribution. Austria, Denmark, Germany, Singapore, Netherlands, Hong Kong, and Switzerland. US product is not affected.
Location
Branchburg, NJ

Frequently Asked Questions

What product was recalled?
Nucleic Acid test intended for screening for MRSA/SA. Each kit has 20 tubes. in vitro diagnostic.. Recalled by Roche Molecular Systems, Inc.. Units affected: 136 kits.
Why was this product recalled?
The cobas MRSA/SA tests may have decreased performance compared to the analytical sensitivity for MSRA detection. A screening failure can lead to potential infection in the colonized patient being tested as well as the spread of MSRA to others. The United States is not impacted, as the cobas MRSA/SA nucleic acid test for use on the cobas liat system is not available in the US.
Which agency issued this recall?
This recall was issued by the FDA Devices on April 4, 2018. Severity: Moderate. Recall number: Z-1195-2018.